A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.

AI can process diverse data sources—ranging from medical images to genetic information to patient voice recordings—to help doctors make more informed decisions. While processing this data individually ...

Miroslav Katsarov is the CEO of Modeshift, a technology company bringing intelligent transportation to small- and mid-size transit agencies. In my previous article, I discussed how the focus on ...

Precision oncology aims to tailor cancer treatments to individual patients by analyzing diverse clinical and pathological ...

Samskip, a global logistics company, has announced its membership in the Digital Container Shipping Association Plus (DCSA+), a collaborative platform aimed at driving the digital transformation of ...